HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Leng Selected Research

Moyamoya disease 3

8/2019[The application of hybrid operation suite in the management of cerebral and spinal vascular diseases and intracranial hypervascular tumors].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Leng Research Topics

Disease

2Neoplasms (Cancer)
08/2019 - 03/2001
2Intracranial Aneurysm (Cerebral Aneurysm)
08/2019 - 01/2018
2Aneurysm (Aneurysms)
08/2019 - 01/2018
1Carotid Stenosis (Carotid Artery Stenosis)
08/2019
1Arteriovenous Fistula
08/2019
1Arteriovenous Malformations (Arteriovenous Malformation)
08/2019
1Vascular Diseases (Vascular Disease)
08/2019
1Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula)
08/2019
1Infections
08/2019
1Moyamoya disease 3
08/2019
1Traumatic Brain Injuries (Traumatic Brain Injury)
08/2019
1Central Nervous System Infections (Central Nervous System Infection)
08/2019
1Pathologic Constriction (Stenosis)
01/2018
1Stroke (Strokes)
01/2018
1Hemorrhage
01/2018
1Cardiovascular Diseases (Cardiovascular Disease)
01/2014
1Pneumonia (Pneumonitis)
12/2011
1Hemolysis
12/2011
1Staphylococcal Pneumonia
12/2011
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2011
1Lymphoma (Lymphomas)
06/2001
1Neoplasm Metastasis (Metastasis)
03/2001
1Hypertrophy
01/2001
1HIV Infections (HIV Infection)
01/2001
1Eosinophilic Fasciitis
01/2001
1Eosinophilia
01/2001
1Septic Shock (Toxic Shock Syndrome)
11/2000
1Arthritis (Polyarthritis)
07/2000
1Pancytopenia
07/2000
1Body Weight (Weight, Body)
07/2000
1Fever (Fevers)
07/2000
1Vascular Skin Diseases
07/2000
1Cryoglobulinemia
03/2000

Drug/Important Bio-Agent (IBA)

1MetalsIBA
08/2019
1CalcineurinIBA
01/2014
1chrysinIBA
12/2011
1Interleukin-6 (Interleukin 6)IBA
01/2011
1efavirenz (Sustiva)FDA Link
01/2001
1Interleukin-10 (Interleukin 10)IBA
01/2001
1Immunoglobulins (Immunoglobulin)IBA
01/2001
1Leukemia Inhibitory FactorIBA
01/2001
1Interleukin-5 (Interleukin 5)IBA
01/2001
1CytokinesIBA
01/2001
1Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
07/2000
1GemcitabineFDA Link
07/2000

Therapy/Procedure

2Therapeutics
06/2001 - 03/2000
1Blood Transfusion (Blood Transfusions)
08/2019
1Length of Stay
08/2019
1Stents
01/2018
1Aftercare (After-Treatment)
01/2011
1Radiotherapy
03/2001
1Drug Therapy (Chemotherapy)
11/2000